common.study.topics.clinical

Measuring Symptom Distress in Cancer Patients

common.study.values.description

New Assessment System in Measuring Symptom Distress in Cancer Patients

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Interview

Complete interview

Quality-of-Life Assessment

Complete quality of life assessment

Questionnaire Administration

Complete questionnaires

participant.views.study.view.additional

participant.views.study.view.scientific-title

Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System

common.study.values.clinical-trial-id

NCT00505245

participant.views.study.view.id

ZdPNwa